TELA Bio Corp (TELA) - Aggregate Business Assets

TELA (TELA Bio, Inc.) - company brandmark

TELA Bio, Inc. (TELA) generates revenue by creating advanced biotransplants, with the sale of OviTex reinforced tissues for plastic surgery and hernia repair serving as the primary profit generator. This price chart, which records total assets at 63.64, complements data regarding logistics and the outsourcing of component manufacturing to third-party contractors. The company is currently betting on internal headcount growth and direct clinic access without pursuing mergers.

TELA (telabio.com) Company Total Assets history from 07/04/2022 to 10/30/2026

Financial and market metric breakdowns for telabio.com (TELA)

- market value and analyst target forecast:
Stock Price TELA Bio|TELA - Consensus Target
- market capitalization indicators:
Market Value TELA Bio, Inc.|TELA - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value of a Share TELA Bio|TELA - Book Capitalization|Market-to-Book Ratio telabio.com|TELA - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio TELA Bio, Inc.|TELA - Long-Term Debt to Capital|Short-Term Debt to Capital TELA Bio|TELA - Company Debts|Debts to Book Capitalization Ratio TELA Bio, Inc.|TELA - Company Long-Term Debts|Short-Term Debt TELA Bio|Quick Ratio telabio.com
- net income and valuation multiples indicators:
TELA - Net Income
Basic company analysis:TELA Bio Corp TELA
Manufactured products of telabio.com

Scaling the TELA Bio, Inc. (TELA) sales force amidst a chronic cash deficit directly impacts the structure of the balance sheet base. A reverse calculation via ROA allows for the determination of the total cost of resources and liabilities, while the total assets chart captures capital management efficiency under conditions of operating losses and the risks of overpaying for the company as the return on assets declines.

Direct competitors

dexcom.com (DXCM) - Company Total Assets|Cumulative Company Assets PEN|NOVT (Novanta Inc) - Aggregate Business Assets|Company Total Assets HAE|INSP (Inspire Medical Systems Inc) - Aggregate Asset Value|Company Total Assets PRCT (PROCEPT BioRobotics)|conmed.com (CNMD) - Company Assets|PLSE - Aggregate Company Assets|Aggregate Asset Value INMD (InMode Ltd)|PMI: Company Total Assets|Surmodics Inc. (SRDX) - Company Total Assets|Aggregate Company Assets Senseonics Holdings Inc|neuropace.com - Total Asset Value of Company|Company Total Assets TCMD|SNWV - Company Assets|Outset - Cumulative Company Assets|Company Total Assets SmartVest ELMD|LNSR: Cumulative Company Assets|avitamedical.com - Aggregate Business Assets|PROF: Company Total Assets|BDMD - Company Total Asset Base|EDAP (EDAP TMS SA) - Company Total Assets|Cumulative Company Assets Bovie Medical (APYX)|Cumulative Company Assets ICCM (IceCure Medical Ltd)|LUNG (pulmonx.com) - Aggregate Asset Value|Aggregate Company Assets CytoSorbents Corporation CTSO|SRTS - Cumulative Company Assets|Zynex Inc - Company Total Assets|Company Assets electroCore, Inc.|RBOT: Company Total Assets|Total Business Assets IINN|ICU (SeaStar Medical) - Company Total Assets|IRIDEX Corp. (IRIX) - Company Total Asset Base|Company Total Assets INBS|Cumulative Company Assets beyondair.net XAIR|Company Total Assets PFSA (Profusa Inc)|Company Total Assets STRATA Skin Sciences Inc. SSKN|GCTK - Aggregate Company Assets|NAOV: Aggregate Company Assets|VERO (Venus Concept Corp) - Cumulative Company Assets|Nuwellis Corp - Aggregate Asset Value|AEMD (Aethlon Medical) - Company Total Assets|Company Assets TransEnterix ASXC|Aggregate Company Assets Avinger (AVGR)|BioSig Technologies (BSGM) - Company Balance Sheet Assets|Cutera, Inc - Cumulative Company Assets|Company Total Assets Know Labs Corporation KNW|Inari Medical, Inc. - Company Total Assets|Company Total Asset Base nevro.com NVRO|reshapelifesciences.com (RSLS) - Aggregate Company Assets|Total Asset Value of Company SILK (Silk Road Medical, Inc.)